Skip to main content

1 Result(s)

within E. Delande Remove this filter

and

  1. No Access

    Article

    Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

    The DHAP regimen (high-dose cytarabine in combination with dexamethasone and cisplatin) with or without rituximab (DHAP+/−R) is one of the most common regimens in daily practice. It is considered the standard ...

    B. Tessoulin, P. Thomare, E. Delande, J. Moynard, T. Gastinne… in Annals of Hematology (2017)